Published :
Tables : 38
Figures : 27
Category : Healthcare
No. of Pages : 177
Report Code : HC-1306
Skin Perfusion Pressure Testing Device Market is estimated to value over USD 72.1 million by 2027 end and register a CAGR of over 8.6% during the forecast period 2020 to 2027. Many diabetic patients around the world develop gangrene which leads to limb amputation. This can be prevented by undergoing skin perfusion pressure (SPP) testing. It is a non-invasive test and is primarily suggested to patients suffering from peripheral arterial disease (PAD). The rising prevalence of diabetes is an important factor contributing to the market growth. Growing activities in medical tourism, especially in Asian countries, is an integral factor liable for the market proliferation. The emphasis of manufacturers on developing advanced devices coupled with rising demand for advanced skin perfusion pressure testing devices can be credited for the market augmentation. Although, in order to operate skin perfusion pressure testing devices, highly trained and skilled resources are required so as to obtain reproducible and accurate results. A dearth of such skilled resources, especially in developing countries, may hamper the use of these testing devices thus impeding market growth. Amputation Procedures Are On a Rise Amongst Diabetic Patients: As per the International Diabetes Federation (IDF), the global incidence of diabetes is predicted to soar from 285 million to over 435 million by the end of 2030. Looking at these market trends, it shows lucrative revenue opportunities for the market which are prominently used for monitoring the ischemic conditions of diabetic patients. Ultrasound and Angiography technologies are standard procedures for diagnosing wound healing testing and PAD. These new techniques have distinctive advantages over conventional blood testing, ankle-brachial index (ABI) testing and other non-invasive techniques. Furthermore, diagnostic laboratories, the ready availability of various imaging techniques and more reliable test outcomes boost the rate of adoption of SSDs over others, thus aidingmarket growth significantly. Major key market players are: Vasamed Incorporated, Moor Instruments, Perimed AB, CorVascular Diagnostics, LLC, ELCAT, Promed Group Co., Ltd., Shenzhen Ricso Technology Co., Ltd., Shenzhen Bestman Instrument Co., ltd., Viasonix, Biomedix (Collaborative Care Diagnostics, LLC), Koven Technology, Inc., Newman Medical. FutureWise Key Takeaways: Multidisciplinary wound management has recently gained popularity owing to knowledge diversification afar from conventional medical practices. Therefore, TBI, SPP, ABI and other vascular tests are now a part of daily diagnostic for nutritionists, infectious disease specialists, endocrinologists, vascular specialists group thus aiding the market growth The systems that are currently available for skin perfusion pressure testing are provisioned with advanced automatic inflation or deflation features, data management software and segmental calculation algorithm. These inbuilt SPP device features enable real-time reporting, data sharing and storage through EMR Skin Perfusion Pressure Testing Device Market Segmentation: By Product Type Systems Laser Doppler SPP System Photo plethysmography System Ultrsound System Accessories and Consumables Pressure Cuffs Electrodes Probes Others By Mode Cart-based devices Portable devices By End User Hospitals Outpatient Centres Diagnostics Centres Clinics Others By Region North America Europe Asia Pacific Latin America Rest of the World Skin Perfusion Pressure Testing Device Market Video Sample: Objectives of the Study: To provide with an exhaustive analysis on the global market by product type, by mode, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe Asia Pacific, Latin America and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Many diabetic patients around the world develop gangrene which leads to limb amputation. This can be prevented by undergoing skin perfusion pressure (SPP) testing. It is a non-invasive test and is primarily suggested to patients suffering from peripheral arterial disease (PAD).
The rising prevalence of diabetes is an important factor contributing to the market growth. Growing activities in medical tourism, especially in Asian countries, is an integral factor liable for the market proliferation. The emphasis of manufacturers on developing advanced devices coupled with rising demand for advanced skin perfusion pressure testing devices can be credited for the market augmentation.
Although, in order to operate skin perfusion pressure testing devices, highly trained and skilled resources are required so as to obtain reproducible and accurate results. A dearth of such skilled resources, especially in developing countries, may hamper the use of these testing devices thus impeding market growth.
Amputation Procedures Are On a Rise Amongst Diabetic Patients:
As per the International Diabetes Federation (IDF), the global incidence of diabetes is predicted to soar from 285 million to over 435 million by the end of 2030. Looking at these market trends, it shows lucrative revenue opportunities for the market which are prominently used for monitoring the ischemic conditions of diabetic patients.
Ultrasound and Angiography technologies are standard procedures for diagnosing wound healing testing and PAD. These new techniques have distinctive advantages over conventional blood testing, ankle-brachial index (ABI) testing and other non-invasive techniques. Furthermore, diagnostic laboratories, the ready availability of various imaging techniques and more reliable test outcomes boost the rate of adoption of SSDs over others, thus aidingmarket growth significantly.
Major key market players are:
Vasamed Incorporated, Moor Instruments, Perimed AB, CorVascular Diagnostics, LLC, ELCAT, Promed Group Co., Ltd., Shenzhen Ricso Technology Co., Ltd., Shenzhen Bestman Instrument Co., ltd., Viasonix, Biomedix (Collaborative Care Diagnostics, LLC), Koven Technology, Inc., Newman Medical.
FutureWise Key Takeaways:
Skin Perfusion Pressure Testing Device Market Segmentation:
By Product Type
By Mode
By End User
By Region
Skin Perfusion Pressure Testing Device Market Video Sample:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Skin Perfusion Pressure Testing Device Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Skin Perfusion Pressure Testing Device Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Skin Perfusion Pressure Testing Device Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Skin Perfusion Pressure Testing Device Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Skin Perfusion Pressure Testing Device Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Systems 7.1.1. Laser Doppler SPP System 7.1.2. Photo plethysmography Systems 7.1.3. Ultrasound Systems 7.2. Accessories and Consumables 7.2.1. Pressure Cuffs 7.2.2. Electrodes 7.2.3. Probes 7.2.4. Others 8. Global Skin Perfusion Pressure Testing Device Market, By Mode Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Cart-based devices 8.2. Portable devices 9. Global Skin Perfusion Pressure Testing Device Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hospitals 9.2. Outpatient Centres 9.3. Diagnostics Centres 9.4. Clinics 9.5 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Vasamed Incorporated 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Moor Instruments 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Perimed AB 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. CorVascular Diagnostics, LLC 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 ELCAT 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Promed Group Co., Ltd. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Shenzhen Ricso Technology Co., Ltd. 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Shenzhen Bestman Instrument Co., ltd 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Viasonix 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Biomedix (Collaborative Care Diagnostics, LLC) 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11 Koven Technology, Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Newman Medical 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Clien
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics